Vincerx Pharma
VINC
$0.57
Share price
-3.01%
Change (1 day)
-55.85%
Change (1 year)
Categories
Vincerx Pharma (VINC) - P/B ratio
P/B ratio as of June 2024 : -27.3
According to Vincerx Pharma's latest financial reports the company has a price-to-book ratio of -27.3.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vincerx Pharma - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.25 | 395.83% |
| 2022-12-31 | 0.4534 | -78.76% |
| 2021-12-31 | 2.14 | -81.47% |
| 2020-12-31 | 11.5 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -6.34 | -76.72% | Bahamas |
 NRC Health
NRC | 15.2 | -155.62% | 🇺🇸 USA |